je.st
news
The Long-Term Investment Case For Amgen
2015-10-11 11:18:04| Biotech - Topix.net
Biotech pioneer Amgen has been caught in the recent bear market that has swept over the Biotech Land over the past couple of months. The stock is down ~$30.00 a share from the recent highs even as the company has seen some positive catalysts over that time frame.
Tags: case
investment
longterm
amgen
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||